NTSAD provides family services, research, and education for
Tay-Sachs, GM-1, Sandhoff, Canavan and allied diseases.
Join our cause to wipe out these genetic diseases.
Inclusion criteria are necessary for a successful clinical trial. Inclusion criteria also help minimize risk in a clinical trial and ensure the proposed therapy is safe and effective. Having a successful trial in which risks are minimized and success of the therapy can be shown is important to allow therapies to continue in future trials and to lead to eventual approval.